Skip to content

The Efficacy and Mechanism of DBS in VIC and NAcc for Refractory OCD

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: Efficacy and Mechanism of Ventral Internal Capsue and Nucleus Accumbens

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04228744
Enrollment
20
Registered
2020-01-14
Start date
2020-01-10
Completion date
2022-12-31
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Brain Stimulation, Obsessive-Compulsive Disorder

Brief summary

This study will evaluate the efficacy and explore the mechanism of deep brain stimulation (DBS) in the ventral internal capsule (VIC) and nucleus accumbens (NAc) for refractory obsessive-compulsive disorder (OCD).

Interventions

DEVICEDBS system

The DBS device utilized in the present study includes a dual-channel neurostimulator kit, lead kit, extension kit, clinician-operated wireless programmer, test stimulator, and patient controller. The lead contains four stimulating contacts. The length of each contact is 1.5 mm, and the spacing between contacts is 1.5 mm. The participants will receive stepwise surgery. The electrodes will be implanted firstly which will be externalized for several days and then the IPG will be implanted. During externalization, the experimenters will record the local field potential and electroencephalography in resting or task-based state with conditions of sham-stimulation or active-stimulation.

Sponsors

University of Cambridge
CollaboratorOTHER
Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of OCD with duration of at least 5 years; 2. Severity rated as severe to extreme illness; 3. Failed adequate trial of at least three specific serotonin reuptake inhibitor (SSRI) antidepressants; 4. Failed augmentation with antipsychotic; 5. Completed or failed to complete adequate trial of cognitive behavioural therapy for OCD; 6. Stable medication regimen for one month before surgery; 7. Signed informed consent;

Exclusion criteria

1. Hoarding as a primary symptom; 2. No other serious psychiatric disorder such as psychotic disorder; 3. Drug or substance use disorder within 6 months except nicotine; 4. Major Neurological/Medical condition; 5. High suicide risk; 6. Pregnancy or lactation; 7. Contraindications to stereotactic surgery; 8. Contraindications to MRI;

Design outcomes

Primary

MeasureTime frameDescription
Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsY-BOCS is used to rate the severity of OCD symptoms by clinicians. Higher score means more severe OCD symptoms.

Secondary

MeasureTime frameDescription
Change in Yale-Brown Obsessive-Compulsive Scale-Second Edition (Y-BOCS-II) ScoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe Y-BOCS-II was created given several overarching concerns about the original Y-BOCS. Each item is rated from 0 to 5, and higher score means more severe OCD symptoms.
Change in Obsessive-Compulsive Inventory - Revised (OCI-R) ScoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe OCI-R is an 18-item self-reported scale that assesses the degree of distress caused by OCD symptoms. Each item is rated from not at all (codes as 0) to extremely (codes as 4), and three items constitute a subtype of OCD symptoms.
Adverse EventsBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 months
Changes in Hamilton Anxiety Scale ScoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe Hamilton Anxiety Scale is a clinician-rated scale. Higher scores indicate more severe anxiety.
Changes in Hamilton Depression Scale-17 ScoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe Hamilton Depression Scale-17 is a clinician-rated scale. Higher scores indicate more severe depression.
Magnetic resonance imaging (MRI) imagesBaseline (preoperative)The MRI images contains resting, multi-tasks related, and structural states.
Change in memoryBaseline (preoperative),6 months or 12 monthsThe CANTAB software research is used to assess memory and learning. The tasks incude spatial working memory task, paired associated learning task, pattern recognition memory task.
Change in impulsivity and compulsivityBaseline (preoperative),6 months or 12 monthsThe computerized tasks are used to measure impulsivity and compulsivity. The tasks include stop single task, beads task, model-based modle-free task and habit task.
Change in Yale-Brown Obsessive-Compulsive Scale-Self Report (Y-BOCS-SR) ScoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe Y-BOCS-SR is a self-report version of the clinician-rated Y-BOCS. It consists of 10 items rated on a 5-point Likert scale (0 to 4) with higher scores denoting greater symptom severity.
Changes in SF-36 scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe 36-Item Short Form Survey (SF-36) is used to measure the quality of life. The higher score means higher quality of life.
Changes in WHOQOL-BREF scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe WHOQOL-BREF is used to measure the quality of life. The higher score means higher quality of life.
Changes in Q-LES-Q-SF scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe quality of life enjoyment and satisfaction questionnaire - short form (Q-LES-Q-SF) is used to measure the quality of life. The higher score means higher quality of life.
Changes in PSQI scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe pittsburgh sleep quality index (PSQI) is used to measure the quality and patterns of sleep. Higher score means poorer quality of sleep.
Changes in PSS-10 scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe perceived stress scale (PSS-10) is used to measure stress levels and contains 10 items rated from never (coded as 0) to very often (coded as 4). Higher score means higher level of stress.
Changes in PANAS scoreBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe positive and negative affective schedule (PANAS) consists of 20 words that describe different feeling and emotions. 10 words constitute negative affect and positive affect subscales. Each word was rated from very slightly or not at all (coded as 1) to extremely (coded as 5). Higher score means higher level of positive or negative affect.
Change in Sheehan Disability ScaleBaseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe Sheehan Disability Scale is a composite of three self-rated items designed to measure the extent to which three major sectors in the patient's life are impaired. The patient rates the extent to which his or her 1) work, 2) social life or leisure activities, and 3) home life or family responsibilities are impaired by his or her symptoms on a 10-point visual analog scale.
Change in Young Manic Rating Scale(YMRS)Baseline (preoperative), 1 month, 3 months, 6 months, 12 months, 18 monthsThe YMRS is a 11-item rating scale used to evaluate manic symptoms. Higher score indicates more severe mania.

Countries

China

Contacts

Primary ContactChencheng Zhang, PhD
i@cczhang.org+086-18217122884

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026